Advertisement
Canada markets open in 2 hours 29 minutes
  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CAD/USD

    0.7310
    -0.0012 (-0.16%)
     
  • CRUDE OIL

    78.13
    -0.35 (-0.45%)
     
  • Bitcoin CAD

    87,695.38
    +20.05 (+0.02%)
     
  • CMC Crypto 200

    1,326.99
    -38.14 (-2.79%)
     
  • GOLD FUTURES

    2,322.70
    -8.50 (-0.36%)
     
  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • NASDAQ futures

    18,173.00
    -22.50 (-0.12%)
     
  • VOLATILITY

    13.53
    +0.04 (+0.30%)
     
  • FTSE

    8,297.61
    +84.12 (+1.02%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6787
    -0.0005 (-0.07%)
     

Stocks in play: Trillium Therapeutics Inc.

Announced that it has priced its previously announced underwritten public offering of 2,750,000 common shares and 3,250,000 Series II Non-Voting Convertible First Preferred Shares. The common shares are being sold at a public offering price of $5.00 U.S. per share and the Series II Non-Voting Convertible First Preferred Shares are being sold at a public offering price of $5.00 U.S. per share. Trillium Therapeutics Inc.